DOYLE WILLIAM F 4
4 · NovoCure Ltd · Filed Mar 7, 2022
Insider Transaction Report
Form 4
NovoCure LtdNVCR
DOYLE WILLIAM F
DirectorExecutive Chairman
Transactions
- Award
Options to Buy Ordinary Shares
2022-03-03$80.59/sh+14,581$1,175,083→ 14,581 totalExercise: $80.59From: 2023-03-01Exp: 2032-02-29→ Ordinary Shares (14,581 underlying)
Footnotes (1)
- [F1]Options to buy 14,581 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates.